NCT00474409WithdrawnPhase 4
A Multicenter, Placebo-Controlled, Double-Blind Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 4
- Status
- Withdrawn
- Sponsor
- Eisai Inc.
- Locations
- 4
- Primary Endpoint
- Changes in the European Evaluation of Vertigo (EEV) scale in 4 weeks.
Study Overview
Brief Summary
The purpose of this study is to determine the efficacy and safety of Betahistine Mesilate in the treatment of patients with vertigo caused by Cerebral Infarction in posterior circulation.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients that have a clinical diagnosis of posterior circulation infarction and vertigo occurring within 1 month after the infarction.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Changes in the European Evaluation of Vertigo (EEV) scale in 4 weeks.
Time Frame: 4 weeks
Secondary Outcomes
- The duration of the vertigo symptom.
Investigators
Study Sites (4)
Loading locations...
Similar Trials
Completed
Phase 1
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice DailyHealthyNCT01915901Biogen175
Completed
Phase 2
BTRX-246040 Study in Participants With Parkinson's Disease With Motor FluctuationsMotor DisorderParkinson DiseaseNCT03608371BlackThorn Therapeutics, Inc.24
Completed
Phase 2
A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride InjectionIndolent B-Cell Non-Hodgkin's LymphomasNCT04569838Chia Tai Tianqing Pharmaceutical Group Co., Ltd.91
Completed
Phase 2
The Effect of Betahistine on Body Weight in Obese SubjectsObesityNCT00409305OBEcure Ltd.280
Completed
Phase 4
The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood FlowGait or Balance Disorder ProblemsNCT01468285Abbott Products27